Khalid Parris

Experience

• 

  Gliamed

  Feb 2002 - Jul 2009

  Scientist

  • Led groundbreaking research on 15+ regenerative immunophilin ligands (RILs), elucidating their pivotal roles in cell reprogramming and tissue regeneration.• Demonstrated RILs' efficacy in myocardial regeneration, achieving complete closure of mouse ear holes and accelerating dermal wound healing by three days.• Initiated and guided research on the interaction between the CD81 astrocytic and the EphA5 neuronal receptor, uncovering their essential roles in establishing CNS homeostasis post-injury, enhancing understanding of oncogenesis, and recovery processes. Show less

• 

  Memorial Sloan Kettering Cancer-Center

  Sept 2009 - May 2010

  Senior Research Technician

  • Processed and analyzed thousands of DNA and RNA samples in a high-throughput core facility, ensuring data accuracy and integrity, by implementing rigorous quality control protocols.• Collaborated with clinical and academic researchers at Memorial Sloan-Kettering Cancer Center, Rockefeller University, and Cornell Medical School, providing critical research support and facilitating cross-institutional knowledge exchange.

• 

  Firmenich, Inc.

  May 2010 - May 2013

  Associate Scientist

  • Led groundbreaking research on 15+ regenerative immunophilin ligands (RILs), elucidating their pivotal roles in cell reprogramming and tissue regeneration.• Demonstrated RILs' efficacy in myocardial regeneration, achieving complete closure of mouse ear holes and accelerating dermal wound healing by three days.• Initiated and guided research on the interaction between the CD81 astrocytic and the EphA5 neuronal receptor, uncovering their essential roles in establishing CNS homeostasis post-injury, enhancing understanding of oncogenesis, and recovery processes. Show less

• 

  Astrix

  May 2013 - May 2015

  Biological Scientist

  • Led a multidisciplinary team in the BioWatch Program, screening environmental samples for biological threats and safeguarding over 50 high-traffic areas in NYC, demonstrating exceptional leadership and commitment to public safety.• Achieved Department of Homeland Security (DHS) security clearance, exemplifying adherence to stringent regulatory standards and maintaining rigorous QA and QC procedures.• Fostered daily communication with the Centers for Disease Control, DHS, and NYC’s Public Health Department, showcasing strong collaboration and reporting skills critical for high-stakes environments. Show less

• 

  The Ohio State University Fisher College of Business

  May 2016 - Aug 2017

  Analyst (Part-Time while completing MBA)

  • Spearheaded collaborations with entrepreneurs from OSU and neighboring universities, facilitating the commercialization of early-stage IP, which enhanced potential industry partnerships for five inventors.• Conducted comprehensive market analysis and played a pivotal role in project selection for funding, significantly supporting innovation and growth across multiple projects.• Assisted OSU's I-Corps program director in a six-week campaign where research teams from prestigious universities pitched projects, effectively fostering cross-university innovation and entrepreneurship. Show less

• 

  Lyganex Bio

  Jun 2016 - Dec 2017

  Co-founder & Chief Scientific Officer

  • Pioneered the development of a small-molecule platform at Lyganex Bio, promoting autologous stem cell-mediated tissue renewal and demonstrating leadership in scientific innovation and technology integration.• Secured first place in REV1’s Spring 2016 Concept Academy and a position in Alexandria’s inaugural 2017 Launch Labs NYC Program, underscoring excellence in competitive analysis and early-stage IP placement.• Led a cross-functional team to validate the drug's MOA, developed protocols, conducted cell biology assays, and successfully pitched to multiple VC groups, which enhanced fundraising efforts. Show less

• 

  Rivertown Therapeutics Inc.

  Jan 2018 - Jun 2021

  VP of Research

  • Formulated scientific methodologies to elucidate the mechanism of action (MOA) for Rivertown's small molecules.• Led competitive analysis and crafted a comprehensive business plan, executive summary, and pitch decks, driving Rivertown's strategic positioning.• Forged a strategic collaboration with a hair pigment researcher, catalyzing Rivertown's growth and expanding its research portfolio.

• 

  The Ohio State University Fisher College of Business

  Apr 2018 - Jul 2018

  Consultant

  • Developed a comprehensive database encompassing over 1300 cancer therapy-related projects, significantly supporting the Center for Entrepreneurship and Innovation's strategic mission by enhancing project visibility.• Spearheaded a collaborative initiative with OSU’s Drug Discovery Institute (DDI) to identify and evaluate marketing opportunities.

• 

  The Ohio State University Wexner Medical Center

  Feb 2020 - Nov 2023

  Cell Therapy Process Developer

  • Executed small-scale expansions of CD19/20/22, GARP, and HIV CAR T cell constructs for OSU's clinical trials.• Orchestrated cross-functional team efforts to author and refine translational protocols, achieving the highest quality standards for OSU's Cell Therapy Laboratory.• Validated GAG, VSVG, and mycoplasma qPCR assays characterize CAR T products.• Trained clinical technicians, ensuring rigorous compliance with regulatory standards.

• 

  The Ohio State University Center for RNA Nanobiotechnology and Nanomedicine

  Nov 2023 - Apr 2024

  Graduate Student

  • Completed a Master's in Biomedical Sciences under RNA nanotechnology expert Dr. Peixuan Guo, focusing on the cutting-edge field of RNA aptamers to innovate translational cell-based cancer therapies.• Conducted in-depth research on RNA aptamers, aiming to revolutionize cancer treatment by enhancing the efficacy of cell-based therapies.• Collaborated with a team of researchers and medical professionals, contributing to the advancement of RNA-based therapeutic applications.

• 

  Outlier

  Apr 2024 - Aug 2024

  Consultant

  • Designed complex scientific prompts and multi-step problems to rigorously test and enhance AI capabilities in cell & molecular biology, genetics, biochemistry, and related domains.• Authored comprehensive explanations, solutions, and scientific rationales to benchmark AI outputs.• Collaborated closely with other subject matter experts to ensure technical accuracy and real-world relevance of outputs.